Macrogenics (MGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -60,465 | -77,287 | -41,036 | -66,966 | -51,545 |
| Depreciation Amortization | 4,463 | 3,185 | 1,589 | 4,730 | 2,862 |
| Accounts receivable | -64,921 | -8,223 | -6,233 | 6,058 | 1,616 |
| Accounts payable and accrued liabilities | 921 | -388 | 1,252 | -1,530 | 170 |
| Other Working Capital | -81,471 | -29,235 | -12,228 | 1,392 | -1,237 |
| Other Operating Activity | 77,412 | 18,073 | 9,766 | -12,057 | 18,168 |
| Operating Cash Flow | $-124,061 | $-93,875 | $-46,890 | $-68,373 | $-29,966 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -46,437 | -26,492 | 10,431 | 112,843 | 110,756 |
| PPE Investments | -1,670 | -1,244 | -529 | -3,546 | -2,926 |
| Other Investing Activity | 0 | 0 | 0 | 40,000 | 0 |
| Investing Cash Flow | $-48,107 | $-27,736 | $9,902 | $149,297 | $107,830 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 66 | 66 | N/A | 3,435 | 3,276 |
| Other Financing Activity | 69,391 | 69,391 | -282 | -2,475 | -2,471 |
| Financing Cash Flow | $69,457 | $69,457 | $-282 | $960 | $805 |
| Beginning Cash Position | 182,840 | 182,840 | 182,840 | 100,956 | 100,956 |
| End Cash Position | 80,129 | 130,686 | 145,570 | 182,840 | 179,625 |
| Net Cash Flow | $-102,711 | $-52,154 | $-37,270 | $81,884 | $78,669 |
| Free Cash Flow | |||||
| Operating Cash Flow | -124,061 | -93,875 | -46,890 | -68,373 | -29,966 |
| Capital Expenditure | -1,670 | -1,244 | -529 | -3,706 | -3,086 |
| Free Cash Flow | -125,731 | -95,119 | -47,419 | -72,079 | -33,052 |